Evidence map›Paper›PMID 27006526›Full record

ArticleMediators of inflammation2016

HIV Progression Perturbs the Balance of the Cell-Mediated and Anti-Inflammatory Adaptive and Innate Mycobacterial Immune Response.

Andrew R DiNardo, Anna M Mandalakas, Gugu Maphalala, Godwin Mtetwa, Temhlanga Mndzebele, Piluca Ustero, Makhosazana Hlatshwayo, Emily M Mace, Jordan S Orange, George Makedonas

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Pathogenesis of Human Immunodeficiency Virus-Journal of clinical medicine · 2020
    Review
  2. The Role of Dendritic Cells in TB and HIV Infection.Journal of clinical medicine · 2020
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Andrew R DiNardoThe Global Tuberculosis Program, Texas Children's Hospital, Immigrant and Global Health, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
Anna M MandalakasThe Global Tuberculosis Program, Texas Children's Hospital, Immigrant and Global Health, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
Gugu MaphalalaNational Tuberculosis Reference Laboratory, Swaziland Health Laboratory Services, Ministry of Health, Mbabane, Swaziland.
Godwin MtetwaThe Global Tuberculosis Program, Texas Children's Hospital, Baylor College of Medicine Children's Foundation-Swaziland, Mbabane, Swaziland.
Temhlanga MndzebeleThe Global Tuberculosis Program, Texas Children's Hospital, Baylor College of Medicine Children's Foundation-Swaziland, Mbabane, Swaziland.
Piluca UsteroThe Global Tuberculosis Program, Texas Children's Hospital, Baylor College of Medicine Children's Foundation-Swaziland, Mbabane, Swaziland.
Makhosazana HlatshwayoThe Global Tuberculosis Program, Texas Children's Hospital, Baylor College of Medicine Children's Foundation-Swaziland, Mbabane, Swaziland.
Emily M MaceDepartment of Pathology and Immunology, Baylor College of Medicine, Texas Children's Hospital Center for Human Immunobiology, Department of Pediatrics, Houston, TX 77030, USA.
Jordan S OrangeDepartment of Pathology and Immunology, Baylor College of Medicine, Texas Children's Hospital Center for Human Immunobiology, Department of Pediatrics, Houston, TX 77030, USA.
George MakedonasDepartment of Pathology and Immunology, Baylor College of Medicine, Texas Children's Hospital Center for Human Immunobiology, Department of Pediatrics, Houston, TX 77030, USA.
Texas Children's Hospital · USBaylor College of Medicine · USMinistry of Health · SZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOur objective is to understand how HIV infection increases the risk of progression from latent tuberculosis (TB) to active disease. We understand now that immunity is a balance of competing immune responses by multiple cell types. Since T-lymphocyte production of interferon-gamma (IFN-γ) in response to Mycobacterium tuberculosis (Mtb) antigens fails to differentiate disease from latent infection, we applied a comprehensive profiling methodology to define immune biomarkers that reliably predict a patient's TB risk.

methodsWe established a cohort of HIV-infected adults with TB disease from Swaziland. Multiparametric flow cytometry was used to quantify the mycobacterial-specific anti-inflammatory (IL-4 and IL-10) and proinflammatory (IFN-γ) immune response.

resultsFrom 12 HIV-infected Swaziland patients with TB disease, the CD4(+), CD8(+), Double Negative, and CD56(+)CD3(-) lymphocytes increase their IL-4 : IFN-γ ratio as HIV disease worsens (Spearman r of -0.59; -0.59; -0.60; and -0.59, resp.; p < 0.05). Similarly, HIV severity is associated with an increased IL-10 : IFN-γ ratio (Spearman r of -0.76; p = 0.01).

conclusionAs HIV disease progresses, both the adaptive and innate branches skew away from an inflammatory and towards anti-inflammatory phenotype.

Indexed as

Adaptive ImmunityAdolescentAdultAntigens, BacterialCD3 ComplexCD4-Positive T-LymphocytesCD56 AntigenCD8-Positive T-LymphocytesFemaleHIV InfectionsHumansImmunity, InnateInterferon-gammaInterleukin-10Interleukin-4MaleAntigens, BacterialCD3 ComplexCD56 AntigenInterferon-gammaInterleukin-10Interleukin-4

Identifiers

PMID27006526
PMCPMC4781991
OpenAlexW2287317883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.